Gentile M., Specchia G., Derudas D., Galli M., Botta C., Rocco S., et al. (2021). Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. HAEMATOLOGICA, 106(1), 291-294 [10.3324/haematol.2019.241513].
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
Botta C.;
2021-01-01
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
106291.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.